Mrak, D., Simader, E., Sieghart, D., Mandl, P., Radner, H., Perkmann, T., Haslacher, H., Mayer, M., Koblischke, M., Hofer, P., Göschl, L., Kartnig, F., Deimel, T., Kerschbaumer, A., Hummel, T., Kornek, B., Thalhammer, R., Stiasny, K., Winkler, S., Smolen, J. S., Aberle, J. H., Aletaha, D., Heinz, L. X., & Bonelli, M. (2022). immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study. Annals of the rheumatic diseases, 81(12), 1750–1756. http://access.bl.uk/ark:/81055/vdc_100169735151.0x000064